Operating income, growth figures, profitability and how our products have behaved.
Mon, 27/07/2020 - 00:00
0 minOperating income, growth figures, profitability and how our products have behaved.
Related
Operating revenue in the first nine months of 2025 was 525.1 million euros, a 7% decrease on the first nine months of 2024, mainly due...
4 min
06/11/2025
Madrid, Spain –21 October 2025. Today, Laboratorios Farmacéuticos Rovi, S.A. (hereinafter, “ROVI”), a pan-European pharmaceutical...
3 min
21/10/2025
Laboratorios Farmacéuticos Rovi, S.A. announces that ROIS Phoenix Inc. (the “Buyer”), a wholly owned subsidiary of ROVI Pharma Industrial...
1 min
29/09/2025
6S3A6894.jpg